FDA PMA FDA Class 3 Approved 🇺🇸 United States

Drug Eluting Permanent Left Ventricular (Lv) Pacemaker Electrode

PMA: P060039 · Supplement: S006 · Decision Feb 2, 2010
Classifications
1
FEI Numbers
22
Registration Numbers
22

Basic Information

Device Name
Drug Eluting Permanent Left Ventricular (Lv) Pacemaker Electrode
Trade Name
ATTAIN STARFIX LEAD
PMA Number
P060039
Supplement Number
S006
Device Class
FDA Class 3
Product Code
OJX
Generic Name
Drug eluting permanent left ventricular (lv) pacemaker electrode
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
February 2, 2010
Date Received
August 27, 2009
Supplement Type
Normal 180 Day Track
Supplement Reason
Labeling Change - Indications/instructions/shelf life/tradename
Expedited Review
N

Advisory Committee Statement

APPROVAL FOR SHELF LIFE EXTENSION FROM 18 TO 24 MONTHS FOR THE ATTAIN STARFIX LEAD MODEL 4195.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
OJX Drug Eluting Permanent Left Ventricular (Lv) Pacemaker Electrode